Mini-Sentinel Funding Raised To $135 Mil. To Support Larger-Than-Expected Data Resource
Executive Summary
The Mini-Sentinel funding ceiling was previously $100 million, based on projections for building data analysis capabilities covering 100 million patients, provided by at least three health care data partners. It has significantly exceeded those goals.
You may also be interested in...
Mini-Sentinel Expanding Drug Safety Efforts To Prospective Surveillance
The effort will complement the FDA-funded project’s existing ability to retrospectively measure exposure to products and then analyze specific adverse outcomes.
Mini Sentinel Alleviates FDA Concern Over Pradaxa Bleeding Issue
Data from the pilot program a “driving factor” in the agency’s decision against changing its recommendations for the blood thinner following reports of increased serious bleeding events.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.